Clal Biotechnology Industries Ltd (CBI) — Strategic Asset Allocation Index
Clal Biotechnology Industries Ltd (CBI) has a Strategic Asset Allocation Index of 3.5% as of December 2022. Strategic assets (PP&E of ILA5.09 Million plus long-term investments of ILA-) total ILA5.09 Million, measured against net assets of ILA144.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Clal Biotechnology Industries Ltd (CBI) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Clal Biotechnology Industries Ltd Strategic Asset Allocation Index (2007–2022)
This chart shows how Clal Biotechnology Industries Ltd's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2022. As of December 2022, the index stands at 3.5%, representing strategic assets of ILA5.09 Million against net assets of ILA144.90 Million ILA. For live market cap and overall valuation, see Clal Biotechnology Industries Ltd (CBI) market capitalisation.
Annual Strategic Asset Allocation Index for Clal Biotechnology Industries Ltd (2007–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Clal Biotechnology Industries Ltd from 2007 to 2022, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Clal Biotechnology Industries Ltd (CBI) net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (ILA) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 3.5% | ILA5.09 Million | ILA5.09 Million | ILA- | ILA144.90 Million | ▼ -1.8 pp |
| 2021 | 5.3% | ILA18.06 Million | ILA18.06 Million | ILA- | ILA338.37 Million | ▲ +2.4 pp |
| 2020 | 2.9% | ILA14.94 Million | ILA14.94 Million | ILA- | ILA513.79 Million | ▼ -0.4 pp |
| 2019 | 3.3% | ILA16.32 Million | ILA16.32 Million | ILA- | ILA497.85 Million | ▼ -21.7 pp |
| 2018 | 25.0% | ILA216.75 Million | ILA7.79 Million | ILA208.96 Million | ILA867.62 Million | ▼ -1.9 pp |
| 2017 | 26.9% | ILA217.23 Million | ILA14.85 Million | ILA202.38 Million | ILA808.20 Million | ▲ +2.8 pp |
| 2016 | 24.1% | ILA181.38 Million | ILA16.54 Million | ILA164.84 Million | ILA752.50 Million | ▲ +7.4 pp |
| 2015 | 16.7% | ILA182.93 Million | ILA17.08 Million | ILA165.85 Million | ILA1.09 Billion | ▲ +2.1 pp |
| 2014 | 14.6% | ILA184.31 Million | ILA10.22 Million | ILA174.09 Million | ILA1.26 Billion | ▲ +4.3 pp |
| 2013 | 10.3% | ILA142.46 Million | ILA10.81 Million | ILA131.65 Million | ILA1.38 Billion | ▲ +9.8 pp |
| 2012 | 0.5% | ILA7.29 Million | ILA7.29 Million | ILA- | ILA1.40 Billion | ▲ +0.3 pp |
| 2011 | 0.2% | ILA2.68 Million | ILA2.68 Million | ILA- | ILA1.11 Billion | ▼ 0.0 pp |
| 2010 | 0.3% | ILA3.38 Million | ILA3.38 Million | ILA- | ILA1.23 Billion | ▼ -0.5 pp |
| 2009 | 0.8% | ILA6.25 Million | ILA6.25 Million | ILA- | ILA782.91 Million | ▼ -0.4 pp |
| 2008 | 1.2% | ILA3.31 Million | ILA3.31 Million | ILA- | ILA274.45 Million | ▲ +0.3 pp |
| 2007 | 0.9% | ILA2.91 Million | ILA2.91 Million | ILA- | ILA309.49 Million | — |